Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Hepatobiliary and pancreatic: rare vascular tumor following treatment for hepatitis C with direct-acting antivirals

Britto K, Cheung W, Cameron R, Roberts SK, Kemp W

(2017), J Gastroenterol Hepatol, 32(12), 1912

DOI: 10.1111/jgh.13916

Impact of viral hepatitis aetiology on survival outcomes in hepatocellular carcinoma: a large multicentre cohort study

Mgaieth S, Kemp W, Gow P, Fink M, Lubel J, Nicoll A, Gazzola A, Hong T, Ryan M, Knight V, Dev AT, Sood S, Bell S, Paul E, Roberts SK

(2017), J Viral Hepat, 24(11), 982-9

DOI: 10.1111/jvh.12717

Safety and efficacy of an 8-week regimen of grazoprevir plus ruzasvir plus uprifosbuvir compared with grazoprevir plus elbasvir plus uprifosbuvir in participants without cirrhosis infected with hepatitis C virus genotypes 1, 2, or 3 (C-CREST-1 and C-CREST-2, part A): two randomised, phase 2, open-label trials

Gane EJ, Pianko S, Roberts SK, Thompson AJ, Zeuzem S, Zuckerman E, Ben-Ari Z, Foster GR, Agarwal K, Laursen AL, Gerstoft J, Gao W, Huang HC, Fitzgerald B, Fernsler D, Li JJ, Grandhi A, Liu H, Su FH, Wan S, Zeng Z, Chen HL, Dutko FJ, Nguyen BT, Wahl J, Robertson MN, Barr E, Yeh WW, Plank RM, Butterton JR, Esteban R

(2017), Lancet Gastroenterol Hepatol, 2(11), 805-13

DOI: 10.1016/S2468-1253(17)30159-0

Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection

BourliÀre M, Gordon SC, Flamm SL, Cooper CL, Ramji A, Tong M, Ravendhran N, Vierling JM, Tran TT, Pianko S, Bansal MB, de L»dinghen V, Hyland RH, Stamm LM, Dvory-Sobol H, Svarovskaia E, Zhang J, Huang KC, Subramanian GM, Brainard DM, McHutchison JG, Verna EC, Buggisch P, Landis CS, Younes ZH, Curry MP, Strasser SI, Schiff ER, Reddy KR, Manns MP, Kowdley KV, Zeuzem S; POLARIS-1 and POLARIS-4 Investigators

(2017), N Engl J Med, 376(22), 2134-46

DOI: 10.1056/NEJMoa1613512

Real-world efficacy and safety of ritonavir-boosted paritaprevir, ombitasvir, dasabuvir ± ribavirin for hepatitis C genotype 1 - final results of the REV1TAL study

Lubel J, Strasser S, Stuart KA, Dore G, Thompson A, Pianko S, Bollipo S, Mitchell JL, Fragomeli V, Jones T, Chivers S, Gow P, Iser D, Levy M, Tse E, Gazzola A, Cheng W, Nazareth S, Galhenage S, Wade A, Weltman M, Wigg A, MacQuillan G, Sasadeusz J, George J, Zekry A, Roberts SK; Australian Liver Association Clinical Research Network (ALA CRN)

(2017), Antivir Ther, 22(8), 699-710

DOI: 10.3851/IMP3168

Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

Polaris Observatory HCV Collaborators

(2017), Lancet Gastroenterol Hepatol, 2(3), 161-76

DOI: 10.1016/S2468-1253(16)30181-9

Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials

Jacobson IM, Lawitz E, Gane EJ, Willems BE, Ruane PJ, Nahass RG, Borgia SM, Shafran SD, Workowski KA, Pearlman B, Hyland RH, Stamm LM, Svarovskaia E, Dvory-Sobol H, Zhu Y, Subramanian GM, Brainard DM, McHutchison JG, Brâu N, Berg T, Agarwal K, Bhandari BR, Davis M, Feld JJ, Dore GJ, Stedman CAM, Thompson AJ, Asselah T, Roberts SK, Foster GR

(2017), Gastroenterology, 153(1), 113-22

DOI: 10.1053/j.gastro.2017.03.047

Five-year efficacy and safety of tenofovir-based salvage therapy for patients with chronic hepatitis B who previously failed LAM/ADV therapy

Lim L, Thompson A, Patterson S, George J, Strasser S, Lee A, Sievert W, Nicoll A, Desmond P, Roberts S, Marion K, Bowden S, Locarnini S, Angus P

(2017), Liver Int, 37(6), 827-35

DOI: 10.1111/liv.13331

Modified thresholds for fibrosis risk scores in nonalcoholic fatty liver disease are necessary in the obese

Ooi GJ, Burton PR, Doyle L, Wentworth JM, Bhathal PS, Sikaris K, Cowley MA, Roberts SK, Kemp W, O'Brien PE, Brown WA

(2017), Obes Surg, 27(1), 115-25

DOI: 10.1007/s11695-016-2246-5

Review article: dyssynergic defaecation and biofeedback therapy in the pathophysiology and management of functional constipation

Skardoon GR, Khera AJ, Emmanuel AV, Burgell RE

(2017), Aliment Pharmacol Ther, 46(4), 410-23

DOI: 10.1111/apt.14174

New onset vitiligo following commencement of infliximab in CrohnÌs disease

Luber R, Chamberlain AJ, Sparrow M

(2017), Intern Med J, 47(8), 972-3

DOI: 10.1111/imj.13498

Declining mortality in critically ill patients with cirrhosis in Australia and New Zealand between 2000 and 2015

Majumdar A, Bailey M, Kemp WM, Bellomo R, Roberts SK, Pilcher D

(2017), J Hepatol, 67(6), 1185-93

DOI: 10.1016/j.jhep.2017.07.024

The effects of diet and lifestyle interventions on insulin resistance in patients with nonalcoholic fatty liver disease: a systematic review

Paris T, George ES, Roberts SK, Tierney AC

(2017), Eur J Gastroenterol Hepatol, 29(8), 867-78

DOI: 10.1097/MEG.0000000000000890

Adding glucose to food and solutions to enhance fructose absorption is not effective in preventing fructose-induced functional gastrointestinal symptoms: randomised controlled trials in patients with fructose malabsorption

Tuck CJ, Ross LA, Gibson PR, Barrett JS, Muir JG

(2017), J Hum Nutr Diet, 30(1), 73-82

DOI: 10.1111/jhn.12409

Author Reply-Bariatric surgery and liver function tests in nonalcoholic fatty liver disease

Ooi GJ, Burton PR, Kemp WW, Roberts SK, Brown WA

(2017), Obes Surg, 27(4), 1060

Clinical and endoscopic predictors of cytological dysplasia or cancer in a prospective multicentre study of large sessile serrated adenomas/polyps

Burgess NG, Pellise M, Nanda KS, Hourigan LF, Zanati SA, Brown GJ, Singh R, Williams SJ, Raftopoulos SC, Ormonde D, Moss A, Byth K, P'Ng H, McLeod D, Bourke MJ

(2016), Gut, 65(3),

Cost analysis of endoscopic mucosal resection vs surgery for large laterally spreading colorectal lesions

Jayanna M, Burgess NG, Singh R, Hourigan LF, Brown GJ, Zanati SA, Moss A, Lim J, Sonson R, Williams SJ, Bourke MJ

(2016), Clin Gastroenterol Hepatol, 14(2),

Prediction of clinically significant bleeding following wide-field endoscopic resection of large sessile and laterally spreading colorectal lesions: a clinical risk score

Bahin FF, Rasouli KN, Byth K, Hourigan LF, Singh R, Brown GJ, Zanati SA, Moss A, Raftopoulos S, Williams SJ, Bourke MJ

(2016), Am J Gastroenterol, 111(8),

Intestinal ultrasound in inflammatory bowel disease

Asthana AK

(2016), J Gastroenterol Hepatol, 31 Suppl 1,

WFUMB position paper. Learning gastrointestinal ultrasound: theory and practice

Atkinson NS, Bryant RV, Dong Y, Maaser C, Kucharzik T, Maconi G, Asthana AK, Blaivas M, Goudie A, Gilja OH, NolsØe C, Nürnberg D, Dietrich CF

(2016), Ultrasound Med Biol, 42(12),

8 9 10 11 12